Epidemiological Investigation of Helicobacter Pylori-infected Patients and the Effect of Eradication Treatment on Dyspepsia Symptoms
1 other identifier
observational
2,242
1 country
26
Brief Summary
The objectives of this multicenter, prospective, observational study were to investigate the incidence of dyspeptic symptoms in patients with Helicobacter pylori (H. pylori) infection and to continuously follow up the remission of dyspeptic symptoms after H. pylori eradication, so as to provide reference for the clinical diagnosis and treatment strategies of patients with H. pylori infection and dyspeptic symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2024
26 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 11, 2024
CompletedFirst Submitted
Initial submission to the registry
May 14, 2024
CompletedFirst Posted
Study publicly available on registry
May 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2025
CompletedDecember 30, 2024
November 1, 2024
1.2 years
May 14, 2024
December 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
the incidence of dyspepsia in patients with Helicobacter pylori infection
Proportion of patients with Helicobacter pylori infection with dyspeptic symptoms
Time 0 when finished the Epidemiological questionnaire and Functional Dyspepsia Symptom Diary
Relief of Helicobacter pylori related dyspepsia
The Functional Dyspepsia Symptom Diary (FDSD) will be used to evaluate the dyspepsia symptoms of the patients
Patients with dyspepsia who have successfully eradicated Helicobacter pylori infection will be followed up for dyspepsia symptoms after 2 months and after 6 months to assess the remission of dyspepsia symptoms
Study Arms (1)
Dyspepsia with Helicobacter pylori infection
Interventions
H. pylori infection was confirmed by 13C/ 14C-breath test and/or rapid urease test under endoscopy and histopathological examination. Epidemiological questionnaire and Functional Dyspepsia Symptom Diary (FDSD) were used to investigate basic information and assess dyspeptic symptoms. Patients with dyspepsia who successfully eradicated Helicobacter pylori infection will be followed up for dyspeptic symptoms after 2 months and 6 months to evaluate the relief of dyspeptic symptoms.
Eligibility Criteria
The study population targets male and female patients aged 15-80 who have not previously been treated for Helicobacter pylori and have been diagnosed via 13C/14C urea breath test or gastroscopy. Participants must be willing and able to give informed consent. Exclusions include individuals under 18 or over 80, those with organic digestive diseases, pregnant or nursing women, those with a history of cancer or partial gastrectomy, and individuals with severe organ dysfunction or congenital diseases. Also excluded are those with symptoms like melena, hematemesis, anemia, or cachexia.
You may qualify if:
- Male or female patients aged 18-80 years
- H. pylori infection diagnosed by 13C/ 14C-UBT (\> 2 times the cutoff value) and/or gastroscopy (rapid urease strong positive and histological positive)
- Treatment-naive patients with Helicobacter pylori
- Ability and willingness to participate in the study and to sign and give informed consent
You may not qualify if:
- Under 18 or over 80 years old
- Organic digestive diseases, such as active peptic ulcer, gastroesophageal reflux, gastrointestinal bleeding, acute/chronic pancreatitis, acute/chronic cholecystitis, gallstones, intestinal obstruction, inflammatory bowel disease, etc.
- Combined with melena, hematemesis, anemia, emaciation and other alarm symptoms
- Pregnant and lactating women
- History of cancer
- History of subtotal gastrectomy
- Severe organ dysfunction of heart, liver, kidney, lung and other important organs and congenital diseases, such as grade IV heart failure, liver failure, uremia, respiratory failure, hemophilia, Wilson's disease, etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (26)
Chongqing Daping Hospital
Chongqing, Chongqing Municipality, China
The Ninth People's Hospital of Chongqing
Chongqing, Chongqing Municipality, China
The People's Hospital of Kaizhou District, CQ
Chongqing, Chongqing Municipality, China
The First Affiliated Hospital of Xiamen University
Xiamen, Fujian, China
The People's Hospital of Wuwei
Wuwei, Gansu, China
The First People's Hospital of Qinzhou
Qinzhou, Guangxi, China
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, China
Yongcheng People's Hospital of Henan Province
Shangqiu, Henan, China
Xuchang Central Hospital
Xuchang, Henan, China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Baotou Central Hospital
Baotou, Inner Mongolia, China
Dalian Friendship Hospital
Dalian, Liaoning, China
The First Affiliated Hospital of Dalian Medical University
Dalian, Liaoning, China
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, Shanghai Municipality, 200127, China
Ruijin Hospital Luwan Branch
Shanghai, Shanghai Municipality, China
Shanghai Construction Group Hospital
Shanghai, Shanghai Municipality, China
Shanghai East Hospital
Shanghai, Shanghai Municipality, China
Shanghai Putuo Liqun Hospital
Shanghai, Shanghai Municipality, China
Shanghai Songjiang Central Hospital
Shanghai, Shanghai Municipality, China
West China Fourth Hospital, Sichuan University
Chengdu, Sichuan, China
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Tianjing, Tianjing, China
The Second People's Hospital of Kashgar, Xinjiang
Kashgar, Xinjiang, China
Second People's Hospital of Jinning District, Kunming City
Kunming, Yunnan, China
Ningbo Hangzhou Bay Hospital
Ningbo, Zhejiang, China
The People's Hospital of Shengzhou
Ningbo, Zhejiang, China
Shengzhou People's Hospital
Shaoxing, Zhejiang, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor of Division of Gastroenterology and Hepatology of Renji Hospital,Professor of Medicine
Study Record Dates
First Submitted
May 14, 2024
First Posted
May 20, 2024
Study Start
March 11, 2024
Primary Completion
May 31, 2025
Study Completion
May 31, 2025
Last Updated
December 30, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share